This led us to consider the possibility of modulating the circadian clock through intracellular electrical signals as a potential therapeutic approach for treating AT, as various environmental cues have been known to regulate the circadian clock [54], [55]. The gene discussed is CLOCK; the disease is ataxia telangiectasia.